A Randomized, Double-Blind, Placebo-Controlled, Crossover Study to Explore the Pharmacokinetics and Pharmacodynamics of TRV130, Morphine, and Placebo in Healthy Adult Male Subjects
Phase of Trial: Phase I
Latest Information Update: 07 Feb 2018
At a glance
- Drugs Oliceridine (Primary) ; Morphine
- Indications Pain
- Focus Therapeutic Use
- Sponsors Trevena
- 07 Feb 2018 Results of pooled data from six phase 1 and phase 2 trial assessing population pharmacokinetic/pharmacodynamic (PK/PD) model of the PK and PD of oliceridine, were published in the Journal of Clinical Pharmacology.
- 03 May 2014 Primary endpoint 'Pain-relief' has been met.
- 03 May 2014 Results presented at the 33rd Annual Scientific Meeting of the American Pain Society.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History